AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
163 hedge funds and large institutions have $1.57B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 26 closing their positions.
855% more call options, than puts
Call options by funds: $268M | Put options by funds: $28M
69% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 26
41% more capital invested
Capital invested by funds: $1.11B → $1.57B (+$458M)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more funds holding
Funds holding: 147 → 163 (+16)
2% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
+$106M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$71M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$32.7M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$28.6M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$25.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$41.1M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$40.3M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$40.1M |
| 4 |
AC
Amici Capital
New York
|
-$17.1M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$16.6M |
AUXL Hedge Fund Activity: Q1 2014 in Review
163 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q1 2014, worth a combined $1.57B — up 41% from $1.11B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new AUXL positions and 26 closed out — a net gain of 18 holders — while 51 added to existing stakes and 52 trimmed.
The largest buyer was Paulson & Co, opening a new position worth an estimated $106M. The largest seller was Deerfield Management, cutting an estimated $41.1M.
- 163 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q1 2014, up from 147 in Q4 2013.
- Funds reported $1.57B of AUXILIUM PHARAMCEUTICALS INC stock for Q1 2014, up 41% quarter-over-quarter.
- 44 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q1 2014 and 26 closed out, a net change of +18 holders.
- The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q1 2014 was Paulson & Co, an estimated $106M added.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q1 2014 was Deerfield Management, an estimated $41.1M sold.
Based on aggregated 13F filings for Q1 2014.